Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14137.56	-30798.38	216.32
Graham Fair Price	-9.59	4.99	5.52
PEG	58.56	-0.90	0.57
Price/Book	-1.41	0.99	1.01
Price/Cash Flow	148.23	9.14	3.68
Prices/Earnings	28.83	16.82	13.05
Price/Sales	40.20	19.91	14.20
Price/FCF	148.23	9.14	3.68
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-14.36	0.58	0.68
Operating Margin	18.81	0.31	0.26
ROA	-23.04	< 0.005	< 0.005
ROE	0.02	0.01	-23.47
ROIC	< 0.005	< 0.005	-24.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	2.16	-99.64
Dividends QOQ	-0.54	0.25	-54.91
EBIT QOQ	0.06	-0.14	124.49
EPS QOQ	0.23	-0.19	-18.75
FCF QOQ	2.06	-0.59	-71.32
Revenue QOQ	0.36	-0.27	-24.30
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.49	0.00	inf
Days Sales Outstanding (DSO)	947.07	1281.80	35.34
Inventory Turnover	185.34	0.00	inf
Debt/Capitalization	0.78	0.78	-0.57
Quick Ratio	0.33	1.01	203.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.37	8.65	3.35
Cash	0.84	0.99	18.32
Capex	-0.01	< 0.005	24.12
Free Cash Flow	2.29	0.94	-58.95
Revenue	0.59	0.43	-27.32
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	< 0.005	1.01	20652631692089.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	167.27	-23728.55	14085.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating